These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29961695)

  • 1. Reproducibility and Utility of the 6-minute Walk Test in Systemic Sclerosis.
    Pugnet G; Marjanovic Z; Deligny C; Boussardon K; Benzidia I; Puyade M; Lansiaux P; Vandecasteele E; Smith V; Farge D
    J Rheumatol; 2018 Aug; 45(9):1273-1280. PubMed ID: 29961695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
    Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis.
    Deuschle K; Weinert K; Becker MO; Backhaus M; Huscher D; Riemekasten G
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S53-9. PubMed ID: 21586219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the 6-minute walk distance in patients with systemic sclerosis.
    Sanges S; Giovannelli J; Sobanski V; Morell-Dubois S; Maillard H; Lambert M; Podevin C; Lamblin N; De Groote P; Bervar JF; Perez T; Matran R; Rémy-Jardin M; Hatron PY; Hachulla É; Launay D
    Arthritis Res Ther; 2017 Dec; 19(1):279. PubMed ID: 29246248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of physiological responses after incremental shuttle walking test and 6-minute walk test in patients with systemic sclerosis.
    Ozcan Kahraman B; Tanriverdi A; Sezgin NH; Acar S; Birlik AM; Koken Avsar A; Akdeniz B; Ozpelit E; Savci S
    Wien Klin Wochenschr; 2024 Mar; 136(5-6):169-176. PubMed ID: 36161531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between left ventricular diastolic dysfunction and six minute walk test in patients with systemic sclerosis.
    Akdogan A; Kaya EB; Sahin A; Okutucu S; Yakut E; Kalyoncu U; Aksoy H; Karadag O; Calguneri M; Tokgozoglu L; Kiraz S; Ertenli I
    Int J Rheum Dis; 2011 Oct; 14(4):379-83. PubMed ID: 22004236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.
    Vandecasteele E; De Pauw M; De Keyser F; Decuman S; Deschepper E; Piette Y; Brusselle G; Smith V
    Int J Cardiol; 2016 Jun; 212():265-73. PubMed ID: 27057932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis.
    Schoindre Y; Meune C; Dinh-Xuan AT; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Jul; 36(7):1481-5. PubMed ID: 19487260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry.
    Gupta R; Baughman RP; Nathan SD; Wells AU; Kouranos V; Alhamad EH; Culver DA; Barney J; Carmona EM; Cordova FC; Huitema M; Scholand MB; Wijsenbeek M; Ganesh S; Birring SS; Price LC; Wort SJ; Shlobin OA
    Respir Med; 2022 May; 196():106801. PubMed ID: 35316723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
    Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test-retest reliability, construct validity and determinants of 6-minute walk test performance in adult patients with asthma.
    Meys R; Janssen SMJ; Franssen FME; Vaes AW; Stoffels AAF; van Hees HWH; van den Borst B; Klijn PH; Burtin C; van 't Hul AJ; Spruit MA
    Pulmonology; 2023; 29(6):486-494. PubMed ID: 36470816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of the breath-holding test in patients with systemic sclerosis.
    Yeo J; Kim JY; Kim MH; Park JW; Park JK; Lee EB
    Rheumatology (Oxford); 2022 Oct; 61(10):4113-4118. PubMed ID: 35040945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test.
    Buch MH; Denton CP; Furst DE; Guillevin L; Rubin LJ; Wells AU; Matucci-Cerinic M; Riemekasten G; Emery P; Chadha-Boreham H; Charef P; Roux S; Black CM; Seibold JR
    Ann Rheum Dis; 2007 Feb; 66(2):169-73. PubMed ID: 16868020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease.
    Wilsher M; Good N; Hopkins R; Young P; Milne D; Gibson A; Suppiah R; Ly J; Doughty R; Dalbeth N
    Respirology; 2012 May; 17(4):647-52. PubMed ID: 22256786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study.
    Ferreira JP; Metra M; Anker SD; Dickstein K; Lang CC; Ng L; Samani NJ; Cleland JG; van Veldhuisen DJ; Voors AA; Zannad F
    Eur J Heart Fail; 2019 Feb; 21(2):218-226. PubMed ID: 30600578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Six-Minute Walk Test to Measure Functional Capacity After Liver Transplantation.
    VanWagner LB; Uttal S; Lapin B; Lee J; Jichlinski A; Subramanian T; Heldman M; Poole B; Bustamante E; Gunasekaran S; Tapia CS; Veerappan A; Wong SY; Levitsky J
    Phys Ther; 2016 Sep; 96(9):1456-67. PubMed ID: 27055540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventilation distribution as a contributor to the functional exercise capacity in patients with systemic sclerosis-associated interstitial lung disease without pulmonary hypertension.
    Andrade FM; Oliveira AD; Lopes AJ
    Braz J Med Biol Res; 2019; 52(8):e8513. PubMed ID: 31365695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiographic Predictors for Worsening of Six-Minute Walk Distances in Patients With Systemic Sclerosis (Scleroderma).
    Kusunose K; Yamada H; Nishio S; Hirata Y; Seno H; Saijo Y; Ise T; Tobiume T; Yamaguchi K; Yagi S; Soeki T; Wakatsuki T; Sata M
    Am J Cardiol; 2017 Jul; 120(2):315-321. PubMed ID: 28532772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement.
    Abdel-Magied RA; Kamel SR; Said AF; Ali HM; Abdel Gawad EA; Moussa MM
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):321-330. PubMed ID: 28079844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.